Hypertension in rheumatoid arthritis.

Authors:V F Panoulas, G S Metsios, A V Pace, H John, G J Treharne, M J Banks, G D Kitas
Language:ENG.
Date:30-5-2008
Journal:Rheumatology (Oxford, England) (1462-0332)
Release:Rheumatology (Oxford). 29 May 2008


Abstract:



RA associates with an increased burden of cardiovascular disease, which is at least partially attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly prevalent, and seems to be under-diagnosed and under-treated among patients with RA. In this review, we discuss the mechanisms that may lead to increased blood pressure in such patients, paying particular attention to commonly used drugs for the treatment of RA. We also suggest screening strategies and management algorithms for HT, specific to the RA population, although it is clear that these need to be formally assessed in prospective randomized controlled trials designed specifically for the purpose, which, unfortunately, are currently lacking.

Copyright:Rheumatology (Oxford, England)

Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, UK, Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece, Department of Psychology, University of Otago, Dunedin, New Zealand, Department of Cardiology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley and ARC Epidemiology Unit, Manchester University, Manchester, UK.
Full text:
Swets Information Services - HTML (needs subscription)
HighWire Press - (needs subscription)
 
Add to my archiveAdd to my archive


Send to a friendSend to a friend